Fintech
German SMEs Face Tighter Bank Lending, Turn to Alternatives
Access to bank loans for German SMEs is tightening despite strong financing needs. About 37.8 percent face restrictive lending, driven by economic weakness, structural issues, and external risks. Firms need liquidity for inventories and cash gaps, turning to alternative lenders like Iwoca, which offers faster but costlier loans and is rapidly expanding lending volumes overall.
Access to bank loans for small and medium-sized enterprises (SMEs) in Germany is becoming more difficult, while the need for financing remains high.
According to the KfW-ifo Credit Hurdle survey, around 37.8 percent of SMEs experienced restrictive lending practices in the fourth quarter of 2025, the highest figure since the survey began. Reasons for this include the weak economy, structural problems in the economy, and external risks, which are prompting banks to adopt a more cautious lending policy.
Record-high lending restrictions push SMEs toward faster, alternative financing despite higher costs and stricter approval rates
The demand for short-term liquidity remains strong. Fabian Platzen, General Manager Germany at SME financier Iwoca, estimates that small and medium-sized enterprises in Germany require annual financing volumes of around 70 to 100 billion euros. He told Table.Briefings that many firms are increasingly relying on external funding to manage working capital needs. Companies are using this financing to build up larger inventories in advance or to bridge temporary liquidity gaps.
This trend reflects a broader shift in corporate strategy, as businesses seek to secure supply chains and reduce exposure to procurement disruptions. As a result, inventory levels are being kept higher than in the past, with firms prioritising stability and resilience over just-in-time efficiency.
The growing need for short-term credit highlights ongoing pressure on cash flow management across the SMEs sector in Germany, particularly in an environment marked by uncertainty in global trade and supply conditions in the coming years.

Small and medium-sized enterprises (SMEs) are therefore increasingly turning to alternative lenders
According to information from Table.Briefings, Iwoca has expanded refinancing for its German business to €350 million, thus doubling its credit line compared to 2024. Iwoca’s managed loan portfolio in Germany increased to more than €275 million within a year.
In the first two months of this year alone, the provider disbursed almost €100 million to new and existing customers. Platzen, Iwoca’s general manager, expects the current refinancing line to be fully utilized as early as the third quarter.
Iwoca’s business model relies on fast loan decisions at a higher price. “We grant loans directly based on up-to-the-minute account information and don’t wait for annual financial statements,” said Platzen.
Many medium-sized businesses (SMEs) only prepare their financial statements in the spring. For this speed, however, companies often pay higher interest rates than with traditional bank loans. Iwoca does not disclose specific interest rates. According to the company, its approval rate is below 50 percent, and its default rate is in the mid-single-digit percentage range.
__
(Featured image by Jakub Zerdzicki via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Table.Briefings. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Africa1 week agoRecord State Funding Strengthens Support for Moroccan Associations in 2024
-
Fintech3 days agoSplint Invest Expands Access to Alternative Assets with Strong Growth and Data-Driven Strategy
-
Business2 weeks agoUnderstanding the Bear’s Eye View: A Clearer Perspective on Market Trends
-
Biotech9 hours agoMajor Pharma Advances: EU Approvals, Vaccine Progress, and Breakthrough Clinical Results



